Atosiban
-
Post Date:
Apr 07,2021
-
Expiry Date:
Apr 07,2022
-
Detailed Description:
Cas No. :90779-69-4
Quantity: 1Kilograms
Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%.
https://www.creative-peptides.com/product/atosiban-item-10-101-05-14.html
-
CAS Registry Number:
90779-69-4
-
Synonyms:
Atosiban [USAN:INN];Atosiban (cGMP);Rwj 22164;1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-threonine-8-L-ornithineoxytocin;1-Deamino-2D-tyr-(OEt)-4-thr-8-orn-oxytocin;Atosibanum;Atosibanum [INN-Latin];ORF 22164;Tractocile;UNII-081D12SI0Z;Oxytocin, 1-(3-mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithine-;1-({(4R,7S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-(4-ethoxybenzyl)-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-ornithylglycinamide;Atosiban Acetate;
-
Molecular Formula:
C43H67N11O12S2
-
Molecular Weight:
994.1886
-
Molecular Structure:
Inquiry